BRPI0519642A2 - método para inibir um declìnio em aprendizagem e/ou memória, kit apropriado para administrar um ou mais antioxidantes a um animal, meio para transmitir informação, e, uso de uma composição - Google Patents

método para inibir um declìnio em aprendizagem e/ou memória, kit apropriado para administrar um ou mais antioxidantes a um animal, meio para transmitir informação, e, uso de uma composição

Info

Publication number
BRPI0519642A2
BRPI0519642A2 BRPI0519642-6A BRPI0519642A BRPI0519642A2 BR PI0519642 A2 BRPI0519642 A2 BR PI0519642A2 BR PI0519642 A BRPI0519642 A BR PI0519642A BR PI0519642 A2 BRPI0519642 A2 BR PI0519642A2
Authority
BR
Brazil
Prior art keywords
animal
learning
inhibiting
decline
memory
Prior art date
Application number
BRPI0519642-6A
Other languages
English (en)
Inventor
Steven Curtis Zicker
Karen Joy Wedekind
Original Assignee
Hills Pet Nutrition Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hills Pet Nutrition Inc filed Critical Hills Pet Nutrition Inc
Publication of BRPI0519642A2 publication Critical patent/BRPI0519642A2/pt
Publication of BRPI0519642A8 publication Critical patent/BRPI0519642A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/105—Aliphatic or alicyclic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/121—Heterocyclic compounds containing oxygen or sulfur as hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/174—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
    • Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
    • Y02P60/87—Re-use of by-products of food processing for fodder production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

MéTODO PARA INIBIR UM DECLìNIO EM APRENDIZAGEM E/OU MEMóRIA, KIT APROPRIADO PARA ADMINISTRAR UM OU MAIS ANTIOXIDANTES A UM ANIMAL, MEIO PARA TRANSMITIR INFORMAçãO, E, USO DE UMA COMPOSIçãO. Um método para inibir um declinio em aprendizagem e/ou memória em um animal compreendendo manter o animal em uma dieta fortificada com antioxidante durante um periodo de pelo menos cerca de 3 horas. A dieta compreende pelo menos um antioxidante em uma quantidade antioxidante total efetiva para obter esta inibição. Os antioxidantes apropriados incluem vitamina E, vitamina C, ácido a- lipóico e farinhas vegetais contendo antioxidante. Os métodos são cerca de utilizáveis para caninos adultos jovens com cachorros.
BRPI0519642A 2004-12-29 2005-12-29 Método para inibir um declínio em aprendizagem e/ou memória, kit apropriado para administrar um ou mais antioxidantes a um animal, meio para transmitir informação, e, uso de uma composição BRPI0519642A8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63992804P 2004-12-29 2004-12-29
US66909705P 2005-04-07 2005-04-07
PCT/US2005/047192 WO2006071919A2 (en) 2004-12-29 2005-12-29 Methods for inhibiting a decline in learning and/or memory in animals

Publications (2)

Publication Number Publication Date
BRPI0519642A2 true BRPI0519642A2 (pt) 2009-07-14
BRPI0519642A8 BRPI0519642A8 (pt) 2017-10-03

Family

ID=36615500

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0519642A BRPI0519642A8 (pt) 2004-12-29 2005-12-29 Método para inibir um declínio em aprendizagem e/ou memória, kit apropriado para administrar um ou mais antioxidantes a um animal, meio para transmitir informação, e, uso de uma composição

Country Status (12)

Country Link
US (1) US8535708B2 (pt)
EP (1) EP1830883B1 (pt)
JP (2) JP2008525528A (pt)
CN (1) CN104304671A (pt)
AU (1) AU2005322015B2 (pt)
BR (1) BRPI0519642A8 (pt)
CA (1) CA2592389C (pt)
DK (1) DK1830883T3 (pt)
ES (1) ES2436181T3 (pt)
RU (1) RU2354136C1 (pt)
WO (1) WO2006071919A2 (pt)
ZA (2) ZA200705197B (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090156658A1 (en) * 2000-10-31 2009-06-18 Hill's Pet Nutrition, Inc. Antioxidant-Containing Food Composition For Use In Inhibiting Histamine Pathways In Companion Animals
US20020076470A1 (en) 2000-10-31 2002-06-20 Colgate-Palmolive Company Composition and method
EP1817058B1 (en) * 2004-11-24 2015-09-02 Hill's Pet Nutrition, Inc. Composition for use in improving liver clearance of xenobiotic substances in an animal
US20090176864A1 (en) * 2004-11-24 2009-07-09 Hill's Pet Nutrition, Inc. Methods For Improving Hepatic and Immune Function In An Animal
US8168161B2 (en) 2004-12-22 2012-05-01 Hill's Pet Nutrition, Inc. Method to promote oral health in companion animals
AU2005322887B2 (en) * 2004-12-30 2010-03-11 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
US8252742B2 (en) * 2004-12-30 2012-08-28 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
CN101287460B (zh) * 2005-08-17 2012-04-25 希尔氏宠物营养品公司 预防和治疗肾病的组合物
EP2224930B1 (en) 2008-01-04 2016-06-15 Nestec S.A. Compositions comprising unsaturated fatty acids and nitric oxide releasing compounds and use thereof for enhancing congnitive and related functions
CA2750153C (en) * 2009-01-05 2016-11-08 Calanus As Biological oil composition, formulations comprising the oil composition, and use thereof to prevent or treat cardiovascular disease
RU2539921C2 (ru) 2009-06-12 2015-01-27 Каланус Ас Композиция из жира веслоногих ракообразных, препарат, содержащий эту композицию, включающую жир, ее применение для снижения накопления висцерального жира, улучшения толерантности к глюкозе, предотвращения или лечения заболеваний и расстройств, связанных с ожирением
EP2453759B1 (en) * 2009-07-14 2015-10-21 Hill's Pet Nutrition, Inc. Pet food compositions including a sustained-release lipoic acid and methods of manufacture and use thereof
WO2011084886A1 (en) * 2010-01-06 2011-07-14 Nestec S. A. Dietary regimens useful for mimicking caloric restriction
JP5425325B2 (ja) * 2013-03-15 2014-02-26 株式会社秋田食肉卸センター 食肉の鮮度保持及びその加工肉の酸敗防止の方法及び飼料添加用組成物
ES2925744T3 (es) * 2013-12-18 2022-10-19 Specialites Pet Food Intensificadores de palatabilidad para alimento para mascotas, método de preparación y utilizaciones de los mismos
CA2951567C (en) 2014-06-12 2023-10-31 Lonza, Inc. Method for decreasing skeletal muscle damage and/or oxidative stress in mammals
EP3389385A1 (en) 2015-12-18 2018-10-24 Lonza Inc. Method and composition for increasing muscle protein synthesis and/or functional strength in mammals as well as method of producing a composition
CN106138037A (zh) * 2016-08-24 2016-11-23 江苏农林职业技术学院 一种抗生物细胞氧化损伤的组合物及其应用
CN108783001A (zh) * 2018-06-28 2018-11-13 佛山市雷米高动物营养保健科技有限公司 具有抗氧化功能的宠物用营养颗粒及其制备方法和使用方法
CN109984251A (zh) * 2019-04-15 2019-07-09 喻洁 一种营养均衡的宠物狗粮及其制备方法
EP4449875A1 (en) * 2023-04-18 2024-10-23 Mars, Incorporated Composition for use for improving or preserving mental health in canine
JP2026048428A (ja) * 2024-09-05 2026-03-17 ユニ・チャーム株式会社 ペットフード製品の製造方法

Family Cites Families (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4006266A (en) 1975-10-08 1977-02-01 The Quaker Oats Company Process for making a dry pet food having a hard component and a soft component
US4247562A (en) 1978-12-21 1981-01-27 The Quaker Oats Company Moist pet food with blood chunks and a fluid gravy system
US5006361A (en) 1980-10-03 1991-04-09 Cox James P Lipid pelletization methods, apparatus and products
US5030458A (en) 1989-11-27 1991-07-09 Shug Austin L Method for preventing diet-induced carnitine deficiency in domesticated dogs and cats
DE58902094D1 (de) 1988-01-28 1992-10-01 Koeltringer Peter Kombinationspraeparat zur behandlung von nervenzell-und nervenfasererkrankungen und verletzungen.
JP2524217B2 (ja) * 1988-04-18 1996-08-14 マルハ株式会社 脳機能改善組成物、学習能力増強剤、記憶力増強剤、痴呆予防剤または痴呆治療剤
US4883672A (en) 1988-04-29 1989-11-28 Shug Austin L Method for preventing diet induced carnitine deficiency in domesticated dogs and cats
PT95826B (pt) 1989-11-09 1997-11-28 Asta Medica Ag Processo para a preparacao de composicoes farmaceuticas contendo como ingrediente activo acido r-alfa-liponico ou acido s-alfa-liponico
US5419283A (en) 1992-04-08 1995-05-30 Ciuffo Gatto S.R.L. Animal chew toy of starch material and degradable ethylene copolymer
US5569670A (en) 1992-06-05 1996-10-29 Asta Medica Aktiengesellschaft Combination medications containing alpha-lipoic acid and related
US5292538A (en) 1992-07-22 1994-03-08 Metagenics, Inc. Improved sustained energy and anabolic composition and method of making
RU2071319C1 (ru) * 1993-08-31 1997-01-10 Акционерное общество закрытого типа "Химбио" Способ улучшения процессов памяти
US5339771A (en) 1993-09-15 1994-08-23 Axelrod Herbert R Animal chew toy containing animal meal
US5894029A (en) 1994-03-21 1999-04-13 Purebred Pet Products, Inc. Method of making pet snack food
DE4427079C2 (de) 1994-07-30 2002-12-19 Viatris Gmbh Verfahren zur Racemisierung von Enantiomeren der alpha-Liponsäure
US5599835A (en) 1994-11-23 1997-02-04 Fischer; Frederick B. Use of DL-lipoic acid as a medical food in the treatment of diabetes mellitus
RU2099078C1 (ru) * 1994-12-08 1997-12-20 Акционерное общество закрытого типа "КОМКОН" Средство, обладающее антистрессовым, стресспротекторным, ноотропным, антиалкогольным и антинаркотическим действием, способы профилактики и лечения с его использованием
US5730988A (en) 1995-04-20 1998-03-24 Lynntech, Inc. Nutritional supplements for improving glucose metabolism
DE19630350C2 (de) 1996-07-26 1998-08-20 Siemens Ag Ultraschallwandler
JPH1042798A (ja) 1996-08-07 1998-02-17 Kagome Co Ltd リコピン含有飼料、並びにリコピン含有の畜肉または 卵
US5977162A (en) 1996-09-16 1999-11-02 Seidman; Michael D. Therapeutic treatment for auditory function
CA2269806C (en) 1996-10-28 2006-01-24 Bernhard H. Van Lengerich Embedding and encapsulation of controlled release particles
US5937790A (en) 1996-12-18 1999-08-17 Showa Denko Kabushiki Kaisha Anti-stress agent for animals and a method of reducing stress in animals
US5976568A (en) 1997-02-21 1999-11-02 Medical Doctors' Research Institute, Inc. Modular system of dietary supplement compositions for optimizing health benefits and methods
IT1291113B1 (it) 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
US6232346B1 (en) 1997-03-27 2001-05-15 Michael J. Sole Composition for improvement of cellular nutrition and mitochondrial energetics
ATE240661T1 (de) 1997-03-27 2003-06-15 Michael J Sole Ernährungszusammensetzung zur verbesserung der zellenenergie
US6080788A (en) 1997-03-27 2000-06-27 Sole; Michael J. Composition for improvement of cellular nutrition and mitochondrial energetics
US5851573A (en) 1997-04-29 1998-12-22 The Iams Company Pet food composition for large breed puppies and method for promoting proper skeletal growth
US6346280B1 (en) 1997-05-15 2002-02-12 University Of Washington Composition and methods for inhibiting the formation of brain amyloid deposits
US5883083A (en) 1997-06-09 1999-03-16 Harlmen, Inc. Dietary supplement for alleviating behavioral problems in canines and reducing seizures in canines and felines
US5916912A (en) 1997-06-16 1999-06-29 The Regents Of The University Of California Dietary composition for enhancing metabolism and alleviating oxidative stress
DE19726519A1 (de) 1997-06-23 1998-12-24 Asta Medica Ag Verfahren zur Herstellung trockener Thioctsäure
US6117477A (en) 1998-03-18 2000-09-12 Kal Kan Foods, Inc. Multicomponent food product and methods of making and using the same
DE19818563C2 (de) 1998-04-25 2003-04-17 Sueddeutsche Kalkstickstoff Verwendung von alpha-Liponsäure zur Verringerung des Appetits und/oder zur Körpergewichtsreduzierung
US6197340B1 (en) 1998-05-28 2001-03-06 Medical Research Institute Controlled release lipoic acid
IT1299191B1 (it) 1998-06-23 2000-02-29 Sigma Tau Healthscience Spa Composizione atta a prevenire e trattare l'osteoporosi e le alterazioni legate alla menopausa
ID28460A (id) 1998-07-08 2001-05-24 Lipogenics Inc Komposisi dan metoda untuk perlakuan dan pencegahan penyakit tulang dengan menggunakan tocotrienol
IT1302307B1 (it) 1998-09-01 2000-09-05 Sigma Tau Healthscience Spa Composizione ad attivita' antiossidante ed atta a migliorarel'utilizzazione metabolica del glucosio, comprendente acetil
CA2347172A1 (en) 1998-10-16 2000-04-27 Societe Des Produits Nestle S.A. Protein material for slow digestion and its use
FR2786100B1 (fr) 1998-11-24 2002-03-01 Aventis Laboratoire Nouvelle application therapeutique de la nicergoline
NZ527924A (en) 1999-01-29 2005-01-28 Mars Uk Ltd Antioxidant compositions and methods for companion animals
US6284786B1 (en) 1999-02-16 2001-09-04 The Center For The Improvement Of Human Functioning, Int'l., Inc. Treatment of cancer using lipoic acid in combination with ascorbic acid
US6238708B1 (en) 1999-02-23 2001-05-29 The Iams Company Composition and process for controlling glucose metabolism in companion animals by dietary starch
US6365211B1 (en) 1999-06-18 2002-04-02 The Procter & Gamble Co. Cooking aid with reduced foaming
MXPA02002195A (es) 1999-09-09 2002-09-18 Nestle Sa Mejoramiento del estado de mascotas viejas.
AU7828200A (en) 1999-09-23 2001-04-24 Juvenon Corporation Nutritional supplement for increased energy and stamina
CA2285490C (en) 1999-10-07 2003-11-18 Michael J. Sole Composition for improvement of cellular nutrition and mitochondrial energetics
US6426362B1 (en) 1999-10-08 2002-07-30 Galileo Laboratories, Inc. Formulations of tocopherols and methods of making and using them
HK1050135A1 (zh) 1999-11-02 2003-06-13 Depomed, Inc. 用於促进将药物给予胃的饭後模式药理学诱导
JP2003513039A (ja) * 1999-11-03 2003-04-08 ジュヴェノン インコーポレイテッド 良性の健忘症を治療する方法
US6379727B1 (en) 1999-12-29 2002-04-30 John F. Addy Flavoring system for pet foods
ES2239582T3 (es) 2000-01-20 2005-10-01 Innovet Italia S.R.L. Una composicion para tratar enfermedades articulares degenerativas.
US20010043983A1 (en) * 2000-01-25 2001-11-22 Hamilton Nathan D. Nutritional supplements for aged pets
US20030060503A1 (en) 2000-01-25 2003-03-27 Juvenon, Inc. Nutritional supplements for mature pets
CZ20022927A3 (cs) 2000-02-01 2003-06-18 Muscletech Research And Development Inc. Doplňky stravy založené na alfa-lipoové kyselině pro zvýšení čisté svalové hmoty a síly
US6669975B1 (en) 2000-02-03 2003-12-30 Mars Incorporated Customized dietary health maintenance system for pets
EP1274319B1 (en) 2000-04-14 2009-08-12 Mars, Incorporated Compositions and methods for improving vascular health
US20020076469A1 (en) * 2000-10-31 2002-06-20 Colgate-Palmolive Company Composition and method
US20020076470A1 (en) 2000-10-31 2002-06-20 Colgate-Palmolive Company Composition and method
US20020115710A1 (en) 2000-10-31 2002-08-22 Zicker Steven Curtis Composition and method
IT1320180B1 (it) 2000-12-29 2003-11-26 Hunza Di Marazzita Maria Carme Preparazioni nutrizionali e terapeutiche dotate di attivita'antiossidante ed in grado di controllare gli eccessi ponderali e
EP1247456A3 (en) 2001-02-28 2003-12-10 Pfizer Products Inc. Palatable pharmaceutical compositions for companion animals
EA006429B1 (ru) 2001-03-09 2005-12-29 Сосьете Де Продюи Нестле С.А. Композиция для предупреждения или восстановления возрастных функциональных дефицитов у млекопитающих и способ ее применения
GB0119052D0 (en) 2001-08-03 2001-09-26 Mars Uk Ltd Foodstuff
JP2003052338A (ja) 2001-08-09 2003-02-25 Unitika Ltd 機能性卵及び養鶏用飼料
DE10151764A1 (de) 2001-10-19 2003-05-08 Basf Ag Kombination von Liponsäure und Glutamin in Lebens- und Arzneimitteln
US20030190343A1 (en) 2002-03-05 2003-10-09 Pfizer Inc. Palatable pharmaceutical compositions for companion animals
JP2003261456A (ja) * 2002-03-08 2003-09-16 Howaizu:Kk 脳の老化予防剤
US6733793B2 (en) 2002-06-04 2004-05-11 Metaproteomics, Llc Oral composition with insulin-like activities and methods of use
US8841344B2 (en) 2002-10-03 2014-09-23 Hill's Pet Nutrition, Inc. Method of using omega-3 fatty acids
DK1641351T3 (da) 2003-07-03 2014-08-25 Hills Pet Nutrition Inc Sammensætninger og fremgangsmåder til at formindske aldersrelateret forringelse af mental aktivitet hos familiedyr
AR045142A1 (es) 2003-07-30 2005-10-19 Novartis Ag Composicion veterinaria masticable ductil de buen sabor
US7078064B2 (en) 2003-12-03 2006-07-18 George Zabrecky Compositions and methods useful for treating and preventing chronic liver disease, chronic HCV infection and non-alcoholic steatohepatitis
WO2005058064A1 (ja) 2003-12-19 2005-06-30 Menicon Co., Ltd. アスタキサンチン配合ペット用食物
EP1952701B2 (en) 2004-09-21 2020-03-04 Société des Produits Nestlé S.A. Improving weight control of elderly pets
US20090176864A1 (en) 2004-11-24 2009-07-09 Hill's Pet Nutrition, Inc. Methods For Improving Hepatic and Immune Function In An Animal
EP1817058B1 (en) 2004-11-24 2015-09-02 Hill's Pet Nutrition, Inc. Composition for use in improving liver clearance of xenobiotic substances in an animal
JP2006219467A (ja) 2005-02-10 2006-08-24 Oriza Yuka Kk 脂肪蓄積阻害剤
BRPI0613000A2 (pt) 2005-07-14 2012-12-04 Hills Pet Nutrition Inc método para aumentar a longevidade de um animal, artigo de fabricação, kit, e, meio de comunicação de informação acerca de ou instruções para a administração a um animal velho de uma composição
JP4765491B2 (ja) 2005-09-02 2011-09-07 リコープリンティングシステムズ株式会社 インクジェット式記録ヘッドの駆動方法及びインクジェット式記録ヘッド並びに画像記録装置
JP2007062332A (ja) 2005-09-02 2007-03-15 Toyo Mach & Metal Co Ltd 射出成形機
DE102005057178A1 (de) 2005-11-30 2007-07-19 Basf Ag Verwendung von Zinksalzen der Liponsäure zur Behandlung von Fettstoffwechselstörungen
JP5119509B2 (ja) 2006-05-18 2013-01-16 ビーエイチエヌ株式会社 活動意欲向上剤
US20070292535A1 (en) 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating arthritic and or osteoporitic conditions
JP2008063234A (ja) 2006-09-04 2008-03-21 Pharma Foods International Co Ltd 慢性腎不全予防・改善組成物
US7282225B1 (en) 2006-09-27 2007-10-16 Occular Technologies, Inc. Composition and methods for improving retinal health
JP5157007B2 (ja) 2007-05-11 2013-03-06 ビーエイチエヌ株式会社 骨強化剤
US20080299286A1 (en) 2007-06-04 2008-12-04 David B Josephson Palatability enhancing compositions and foods for pets, and methods regarding the same
CA2691691C (en) 2007-06-20 2013-09-24 Seth J. Baum Compositions and methods of treating chronic kidney disease
BRPI1007054A2 (pt) 2009-01-16 2015-08-18 Hills Pet Nutrition Inc Composição, e, métodos para previnir ou tratar obesidade, para controlar o peso, para diminuir a gordura corporal, e para aumentar a massa corporal magra em um animal de estimação.

Also Published As

Publication number Publication date
JP2008525528A (ja) 2008-07-17
CN104304671A (zh) 2015-01-28
AU2005322015B2 (en) 2010-02-25
US8535708B2 (en) 2013-09-17
ES2436181T3 (es) 2013-12-27
WO2006071919A2 (en) 2006-07-06
RU2007129001A (ru) 2009-02-10
WO2006071919A3 (en) 2006-08-17
BRPI0519642A8 (pt) 2017-10-03
JP2012246292A (ja) 2012-12-13
ZA200705197B (en) 2014-06-25
EP1830883B1 (en) 2013-10-09
EP1830883A4 (en) 2008-03-05
RU2354136C1 (ru) 2009-05-10
AU2005322015A1 (en) 2006-07-06
CA2592389C (en) 2013-05-14
CA2592389A1 (en) 2006-07-06
US20090004299A1 (en) 2009-01-01
EP1830883A2 (en) 2007-09-12
ZA201401388B (en) 2015-05-27
DK1830883T3 (da) 2013-11-25

Similar Documents

Publication Publication Date Title
BRPI0519642A2 (pt) método para inibir um declìnio em aprendizagem e/ou memória, kit apropriado para administrar um ou mais antioxidantes a um animal, meio para transmitir informação, e, uso de uma composição
BRPI0317696B8 (pt) composição para branqueamento
DE60319345D1 (de) Gewichtsmanagementsystem für übergewichtige tiere
AR031283A1 (es) Composicion y metodo de dieta para animales
AR052837A1 (es) Composiciones que contienen hierro
BRPI0412332A (pt) método para aumentar nìveis de antioxidante no sangue em um felino, e, composição para dieta adequada para alimentar animais de companhia jovens
BRPI0514794A (pt) métodos para fornecer nutrição para um animal, para promover o bem estar de um animal, para prescrever uma dieta de bem estar para um animal, e para construir uma matriz de composições alimentìcias para um espécie animal, ração para um animal, sistema auxiliado por computador, kit, e, meio para comunicar informação sobre ou instruções para misturar e administrar uma ração
HN2004000023A (es) Mascadura para animales
BRPI0519773A2 (pt) métodos para intensificar a palatabilidade de uma composição para consumo por um animal e para aumentar a quantidade de uma composição ingerida por um animal, kit, composição, meio para comunicar informação, e, método para preparar uma composição para consumo por um animal
ATE391514T1 (de) Gewichtskontrollsystem für adipöse tiere
BRPI0512274A (pt) derivados de piperazina aril-substituìdos
BRPI0519429A2 (pt) composiÇço adequada para melhorar funÇço renal em um animal, mÉtodo para melhorar a funÇço renal em um animal, kit adequado para administrar composiÇÕes para melhorar a funÇço renal a um animal, meio para comunicar informaÇço, e, uso de uma composiÇço
BRPI0518579A2 (pt) mÉtodo para aumentar a atividade de cÉlula exterminadora natural em um animal, kit adequado para alimentar Ácido lipàico a um animal, meio para comunicar informaÇço, composiÇço, uso da composiÇço que compreende Ácido lipàico, e, mÉtodo para aumentar a resposta imune em um animal
NO20074934L (no) Reduksjon av fordoyeligheten av fosfor i dyreernaering
BRPI0418726A (pt) naftalenossulfonato de clopidogrel cristalino ou hidrato do mesmo, método para sua preparação e composição farmacêutica contendo o mesmo
CR8240A (es) Hidrolizado de colageno
BRPI0418764A (pt) uso de espinosina ou um derivado ou sal da mesma fisiologicamente aceitável
BRPI0511282A (pt) ração ou aditivo de ração contendo alcalóide
AR045853A1 (es) Metodo y composicion para mejorar la capacidad de aprender en un cachorro o gatito
BRPI0517429A (pt) composição de ração, método para intensificar a palatabilidade de uma composição de ração e para reduzir o odor de excreta de animal, kit, e, meio para comunicar informação sobre ou instruções de uso das composições, dos métodos, ou dos kits
BRPI0514260A (pt) composições alimentìcias para animais de estimação tendo uma propriedade de relaxamento definida
BRPI0413873A (pt) método para tratar ou prevenir um ezoar ou tricobezoar em um mamìfero, composição para consumo animal, refeição para animal, brinquedo para animal, suplemento nutricional, e, método para auxiliar a perda de peso ou reduzir o ganho de peso em um animal
MXPA05013208A (es) Metodos para prevenir el hipertiroidismo en un gato y composicion que comprende selenio y yodo limitados.
AR035988A1 (es) Derivados de pirrolo-(3,4-b)quinoleina, su procedimiento de preparacion y su uso para la preparacion de medicamento
BRPI0511563A (pt) uso de bactéria brevibacillus parabrevis, sistema de aqüicultura, aqüiculura e aditivo para a mesma

Legal Events

Date Code Title Description
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]

Free format text: SOLICITA-SE A REGULARIZACAO DA PROCURACAO, UMA VEZ QUE BASEADO NO ARTIGO 216 1O DA LPI, O DOCUMENTO DE PROCURACAO DEVE SER APRESENTADO EM SUA FORMA AUTENTICADA; OU SEGUNDO PARECER DA PROCURADORIA, DEVE CONSTAR UMA DECLARACAO DE VERACIDADE, A QUAL DEVE SER ASSINADA POR UMA PESSOA DEVIDAMENTE AUTORIZADA A REPRESENTAR O INTERESSADO, DEVENDO, PORTANTO CONSTAR NO INSTRUMENTO DE PROCURACAO, OU NO SEU SUBSTABELECIMENTO.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A23K 1/17 , A23K 1/165

Ipc: A23K 1/16 (2006.01), A23K 1/18 (2006.01)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A23K 20/174 (2016.01), A23K 20/158 (2016.01), A23K

B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 13A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2495 DE 30-10-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.